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All multicellular organisms protect themselves against
pathogens using sophisticated immune defenses. Func-
tionally interconnected humoral and cellular facilities
maintain immune homeostasis in the absence of overt
infection and regulate the initiation and termination of
immune responses directed against pathogens. Immune
responses of invertebrates, such as flies, are innate and
usually stereotyped; those of vertebrates, encompassing
species as diverse as jawless fish and humans, are
additionally adaptive, enabling more rapid and efficient
immune reactivity upon repeated encounters with a path-
ogen. Many of the attributes historically defining innate
and adaptive immunity are in fact common to both, blur-
ring their functional distinction and emphasizing shared
ancestry and co-evolution. These findings provide indica-
tions of the evolutionary forces underlying the origin of
somatic diversification of antigen receptors and con-
tribute to our understanding of the complex phenotypes
of human immune disorders.Moreover, informed by phylo-
genetic considerations and inspired by improved knowl-
edge of functional networks, new avenues emerge for
innovative therapeutic strategies.
Introduction
All multicellular organisms rely on dedicated immune de-
fense systems for their survival. Over a period of several
hundred million years, a bewildering variety of defense
strategies has emerged. Individual species typically employ
many of these mechanisms simultaneously to achieve
functional redundancy for one of an organism’s most im-
portant facilities. The presence of multi-layered humoral
and cellular immune systems is as vital for invertebrates
as it is for humans. Indeed, our own highly sophisticated
immune system exemplifies this functional diversity. Non-
specific chemical defenses, such as those initiated by the
broadly reactive C3 complement component, co-exist with
cellular effector mechanisms, the latter best illustrated by
cytotoxic T lymphocytes that exhibit exquisite target spec-
ificity for their peptide antigens to the level of single amino
acids.
Historically, immune functions were conceptually divided
into two separate, for the most part functionally indepen-
dent, domains. So-called innate defenses were thought
to rely on hard-wired programs of enzymatic and cellular
activation, underlying stereotyped immune responses ob-
served in invertebrates. On the other hand, the so-called
adaptive responses of vertebrates, typified by the capacity
for memory formation, were attributed to the function of
different types of lymphocytes. This dichotomy of design
was seemingly supported by successive appearance in
evolutionary history, innate responses being present in
invertebrates, and adaptive responses being the hallmarkDepartment of Developmental Immunology, Max Planck Institute of
Immunobiology and Epigenetics, Stuebeweg 51, D-79108 Freiburg,
Germany.
E-mail: boehm@immunbio.mpg.deof vertebrate immune systems. However, recent research
has led to the realization that innate immune systems also
incorporate certain aspects of immune memory and that
innate and adaptive immune functions are intimately linked.
Many of these fundamental insights have emerged from
comparative analyses, albeit from a limited number of model
species. Hence, an evolutionarily informed view of immune
functions promises not only to change our perception of
the network structure of the immune system but also to
lead to non-intuitive strategies aimed at interfering with
states of immunodeficiency or immune deregulation.
In this review, I discuss recent developments to illustrate
why research on animals separated from humans by several
hundred million years of independent evolution provides
crucial information for clinical research and modern medical
practice.
Evolution of Innate and Adaptive Features of Immune
Systems
The immune systems of invertebrates [1–3], comprising the
great majority of animal species on earth [4], are surprisingly
complex and compare favorably with those of vertebrates
[5–12] in terms of the multitude of mechanisms employed
for immune defense, the plethora of immune-related mole-
cules and the diversity of effector cell types. Insects, for
instance, are capable of mounting cellular and humoral
responses to invading pathogens; however, in contrast to
vertebrates, no antigen-triggered proliferative responses
have yet been demonstrated. Immune recognition in insects
occurs directly or indirectly through germline-encoded pat-
tern recognition receptors, such as Toll [3,13–15]. Immune
responses employ multiple effector mechanisms: phago-
cytosis or encapsulation of pathogens; activation of spe-
cific enzymes, for instance the phenoloxidase cascade, to
generate cytotoxic intermediates, such quinolones [3]; and
expression of antimicrobial peptides [16].
Interestingly, some of the molecules implicated in host
defense even exhibit somatic diversification, a phenomenon
that was previously thought to be a distinguishing feature
of vertebrate immune systems. In arthropods, for instance,
this occurs by alternative splicing of the Dscam molecule,
resulting in the formation of thousands of isoforms [17];
in mollusks, limited somatic diversification, possibly by a
mechanism akin to somatic hypermutation, targets fibrin-
ogen-related proteins (FREPs) [18], which are lectin-like
molecules found in the hemolymph and capable of forming
immune-complex-like aggregates [19]; in echinoderms, pro-
teins of the Sp185/333 gene family appear to be somati-
cally diversified [20]. Even more intriguingly, an infection
can lead to increased, sometimes even cross-protecting
resistance against pathogens other than those eliciting the
primary response [21–24], and long-lasting effects on the
composition of immune effector cell types, such that, for
instance, mosquitoes are protected from Plasmodium para-
site reinfection owing to increased numbers of granulocytes,
a special subpopulation of hemocytes [25]. This kind of
memory in invertebrates represents a kind of heightened
state of alert and is referred to as ‘trained immunity’ [26] to
distinguish it from the adaptive immunological memory in
vertebrates that is based on clonal selection of immune
effector cells [27]. Hence, as immune functions of
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Figure 1. Successive evolutionary emergence
of myeloid and lymphoid cell types underlying
the cellular arms of metazoan immune
systems.
Initially, immune systems relied on the func-
tion of multi-purpose myelomonocytic cells
arising from the hematopoietic cell lineage;
phagocytosis was one of their major pri-
mordial autonomous immune defense func-
tions; in vertebrate immune systems, they
additionally function as antigen-presenting
cells. Lymphocytes represent an innova-
tion of vertebrates and occur in two forms.
‘Innate’ lymphocytes, such as natural killer
cells, are characterized by variegated ex-
pression of germline-encoded antigen recep-
tors, exhibit certain features of immune
memory and participate in lymphoid organ
development as so-called lymphoid tissue
inducer cells. ‘Adaptive’ lymphocytes are
distinguished by expression of somatically
assembled antigen receptors, in a ‘one recep-
tor — one cell’ fashion; such uni-committed
lymphocytes probably emerged at a later
point than ‘innate’ lymphocytes. Clonal ex-
pression of somatically assembled antigen
receptors underlies further adaptive func-
tions, such as affinity maturation and class
switch recombination of immunoglobulins,
and specific memory. Metazoan immune sys-
tems additionally possess humoral defense
systems. AgR, antigen receptor; Ig, immuno-
globulin; Ag, antigen.
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R723invertebrates are studied in greater detail, it appears that
they exhibit numerous hallmarks previously associated
with vertebrate ‘adaptive’ immunity (Figure 1).
Hallmarks of Vertebrate Immune Systems
Vertebrates, a minor fraction of all known animal species,
comprise two clades, the jawless vertebrates, consisting
of approximately 100 species of hagfish and lamprey [28],
and jawed vertebrates, encompassing tens of thousands
of species, including mammals [4]. Previously, it was
thought that the immune systems of vertebrates were char-
acterized by the specific acquisition of adaptive immune
functionalities, thus distinguishing them from the immune
systems of invertebrates. However, as a consequence of
the recent findings on invertebrates referred to above, and
the findings on the innate arm of vertebrate immune sys-
tems described below, the functional distinctions between
innate and adaptive immunity are becoming more and
more blurred; indeed, the use of these terms— in both onto-
genetic and phylogenetic contexts — is considered to
create an unnecessary obstacle to conceptual progress
[8,29,30]. This functional convergence is mirrored in the
unexpected homologues in the molecular pathways in-
volved in the development and function of blood cells
of vertebrates and at least some invertebrate phyla [31].
Notwithstanding these developments, it is clear that verte-
brate immune systems exhibit unique innovations, the
most obvious being the presence of cells of the lymphoid
lineage; furthermore, lymphocytes expressing somatically
assembled receptors usually do so in a way that each lym-
phocyte is equipped with a single receptor [6], a unique
advantage when it comes to purging the repertoire of self-
reactive cells and generating immune memory, as dis-
cussed below (Figure 1).Somatic Diversification of Antigen Receptors
Vertebrates use stunningly efficient somatic diversification
processes to generate an anticipatory repertoire of structur-
ally diverse antigen receptors that are expressed by two
functionally distinct lineages of lymphocytes: antibody-
producing B cells, and T cells that are associated with cyto-
lytic and helper functions [6]. Interestingly, the types of
genes that are subjected to somatic diversification in the
two vertebrate clades are entirely different. Jawless verte-
brates rely on leucine-rich-repeat-containing antigen recep-
tors termed variable lymphocyte receptors (VLRs) [7,12].
VLRs are assembled from incomplete genomic elements
by a gene conversion-like process [32] — a form of homolo-
gous recombination that is initiated by DNA double-stranded
breaks and results in non-reciprocal transfer of genetic
information. In the case of VLRs, this is presumably achieved
by cytidine deaminases [33] in a lineage-specific fashion,
with CDA1 being involved in VLRA assembly, and CDA2 in
VLRB assembly [34]. The diversity of VLRs is generated by
combinatorial use of variable numbers of leucine-rich repeat
(LRR) elements and a patchwork-like assembly process
[7,12]. B-like cells of lamprey express the VLRB isotype
[34–36], which can be secreted in the same way as anti-
bodies [37,38]. By contrast, the VLRA and VLRC antigen
receptors [34,39,40] are expressed by two distinct T-cell-
like lineages and are situated on the cell membrane, akin to
a T-cell receptor (TCR) [34].
The repertoire of antigen receptors of jawed vertebrates
is the result of both combinatorial and junctional diversity,
collectively referred to as V(D)J recombination [41]. Junc-
tional diversity leads to the generation of non-templated
sequence elements, an important mechanistic difference
between jawless and jawed vertebrates; the random
sequences occur in the third complementarity-determining
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Figure 2. Distinct modes of antigen receptor
expression in the immune system.
(A) The assembly of antigen receptor genes
in somatic cells occurs in a step-wise fashion.
If assembly on the first allele is functional,
the assembly process is stopped, and the
receptor encoded by this gene is expressed.
If assembly on the first allele fails, an attempt
is made on the second allele. If both attempts
fail, a lymphocyte is presumed to abort further
differentiation. (B) The expression of germ-
line-encoded antigen receptors often occurs
in a variegated fashion, in such a way that
different cells express different subsets of
the antigen receptor repertoire.
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R724regions (CDR3) of immunoglobulins (Igs) and TCRs (encod-
ing parts of the antigen-binding surface) and are the result
of an error-prone non-homologous end-joining process,
initiated by recombination-activating gene (Rag) family
proteins [41]. Despite these mechanistic differences, the
available evidence suggests that the degrees of diversity in
antigen receptor repertoires achievable by somatic di-
versification in jawless and jawed vertebrates are essentially
similar [36,42]. It should be noted that cytidine deaminases
are also employed for antigen receptor gene diversification
in jawed vertebrates, both during the generation of the
primary repertoire of immunoglobulins and for their subse-
quent diversification during an immune response; indeed,
they may form part of an ancestral mechanism of immune
defense that targets foreign genetic material, establishing
genetic and functional continuity between the immune
systems of invertebrates and of the two branches of
vertebrates [6,7,9–11].
Monoallelic Expression of Antigen Receptors
A second characteristic of somatically diversified anti-
gen receptors in vertebrates is their expression mode[34,35,40,43,44]; because only one
receptor is expressed per cell, each
lymphocyte and all of its progeny
(referred to as a clone) are endowed
with a unique molecular and functional
signature (Figure 2A). By contrast, the
expression of germline-encoded addi-
tional receptors on lymphocytes, such
as Toll-like receptors (TLRs), is gener-
ally not clonal, as lymphocytes ex-
pressing different types of somatically
assembled antigen receptors might still
express the same type(s) of germline-
encoded receptors (Figure 2B). While
it could be argued that somatic diversi-
fication already occurs in the immune
systems of invertebrates, albeit on a
much smaller scale than in vertebrates,
clonal expression of antigen receptors
possessing unique specificities has
not yet been detected in invertebrates;
it thus represents a distinguishing
feature of vertebrate immune systems.
Note, however, that the ‘one cell —
one receptor’ mode of expression can
be considered as the extreme case of variegated expression
of immune-related receptors that is known to occur
frequently in the immune systems of both invertebrates
and vertebrates: for instance, hemocytes — the principal
immunocyte of arthropods [45] — express only a subset
of the many thousands of isoforms of Dscam that are
generated by alternative splicing [17]; likewise, each natural
killer (NK) cell, a form of ‘innate’ lymphocyte of vertebrates
responsible for the detection of infected or mutated cells
of the body, expresses only a subset of receptors specifi-
cally surveying the presence of self-structures expressed
by healthy cells [46]. Nevertheless, because expression of
single specificities arising from somatic assembly is a feature
of the lymphocytes of both jawless and jawed vertebrates, it
must have conferred unique advantages to their immune
systems, although it remains unclear why this is the case.
However, it has been suggested that, because somatic
diversification involves the risk of creating self-reactive
receptors (that are generally eliminated or functionally
incapacitated), expression of single specificities maximizes
the efficiency with which the repertoire of self-tolerant cells
can be generated in primary lymphoid organs [6]. Hence, it
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R725is possible that the clonal expression of single-specificity-
type receptors that is observed for lymphocytes in the two
groups of vertebrates arose by convergent evolution.
Memory Response
Clonal expression may also prove useful during the imple-
mentation of memory responses. Immune effector cells
depend on trophic support for their maintenance; T cells,
for instance, require the cytokine interleukin-7 (IL-7) and
the presence of weakly reactive self-antigens [47]. However,
because the limited supply of trophic factors essentially
determines the absolute number of effector cells of a par-
ticular type that can be maintained by an organism, this
resource must be carefully managed. When antigen receptor
specificities are clonally distributed among different effector
cells, an infection usually addresses only a small proportion
of antigen-specific cells; hence, it is possible to increase
their frequency considerably without significantly compro-
mising the magnitude of the remaining naı¨ve repertoire
(required for possible subsequent infection by other kinds
of pathogens). Considering that naı¨ve and memory cells
may have different requirements for maintenance [48,49],
the advantage of this design becomes even more apparent.
Because the magnitude of an immune response depends
to a large extent on the frequency of relevant antigen-
specific effector cells, a secondary immunological response
is much more efficient than a primary response; moreover,
when compared to that of naı¨ve cells, the ‘activated’ state
of memory cells enables faster deployment of anti-pathogen
responses.
Immunological memory, long considered a critical and
defining aspect of ‘adaptive’ responses in vertebrates, has
now also been found to occur in an ‘innate’ context. For
instance, NK cells employ a series of activating and inhibi-
tory receptors to integrate a multitude of signals from the
environment. During development, NK cells are equipped
with different combinations of these receptors through the
process of variegated expression [46]; once their net inhibi-
tory potential — the result of a process referred to as
licensing — is overturned by viral infection or an encounter
with tumor cells, the activated fraction in the NK repertoire
can transit to a memory-like state [50]. Hence, a subsequent
memory response exhibits features of antigen specificity.
For instance, during infections with mouse cytomegalovirus,
NK cells expressing the activating receptor Ly49H recognize
the viral m157 glycoprotein, undergo expansion, contrac-
tion and memory cell formation and, upon re-infection,
demonstrate enhanced cytolytic function and cytokine
production, the classical signature of an adaptive memory
response [50].
An Evolutionary Enigma
The two groups of extant vertebrates share many principles
of immune system design and development (Figure 1), indi-
cating that these key features must have been present in
their common ancestor [6]. However, it seems likely that
wholesale somatic diversification of antigen receptors was
not yet present in the hypothetical ancestral vertebrate.
Rather, at some point after the divergence of the two
morphologically (and presumably also ecologically) different
groups of vertebrates, their respective ancestors must have
experienced a similar type of selection pressure that even-
tually led to the evolution of mechanistically distinct but
functionally similar somatic diversification of the antigenreceptors expressed on lymphocytes.What could this evolu-
tionary force have been?
Origin of Somatic Diversification of Clonally Expressed
Antigen Receptors
The morphological complexity of vertebrates is generally
believed to be greater than that of invertebrates and it has
been suggested that the increase ofmorphological and func-
tional complexity was unusually fast during the early stages
of vertebrate evolution [51–53]. This rapid progress might
have resulted in a greater variety of habitable ecological
niches per species and consequently in a heightened sus-
ceptibility to infection by a wider spectrum of pathogens.
The exposure to the diverse requirements of their expanded
habitats may thus have provided the evolutionary force for
more sophisticated immune defenses in early vertebrates
[54]. Thus, while increased morphological complexity might
have increased vulnerability to pathogen attack, it also af-
forded unprecedented opportunities for elaborating novel
types of immune effector cells that could eventually be inte-
grated into multi-dimensional regulatory circuits of immune
defense (Figure 1).
Host Adaptations to a Super-Organismic Lifestyle
An alternative, but not mutually exclusive hypothesis posits
that the vertebrate-specific innovations in the immune
system provided the basis for the evolution of complex
mutualistic relationships between the vertebrate host and
beneficial microbes [55] (Figure 3). Mutualism between
host and microbiome greatly expands the metabolic facility
of the resulting super-organism (a sociological term recently
popularized by work on insect societies [56]), to the benefit
of both parties [57]. Indeed, numerous examples exist for
invertebrates to support this notion, which also applies to
humans, as evidenced, for instance, by the production of
vitamins by colonic bacteria as a component of complex
networks of inter-specific and intra-specific metabolic inter-
actions [58]. Hence, if metabolic proficiency and/or lifestyle
of a vertebrate depend to a greater extent on the synthetic
facilities of the microbiome than do those of their non-verte-
brate cousins, conditions conducive to species-rich micro-
biomes might have been favored in the early stages of
vertebrate evolution.
In considering the interactions between host and micro-
biome, it is important to distinguish between resident
(autochthonous) flora and passenger microbes (allothonous
flora, i.e. food or pathogens). Whereas the former would
be the target of evolving mutualistic interactions, undesired
inhabitants potentially necessitated the ability to initiate
immune defenses. Could it be possible then that an immune
system employing structurally diversified antigen receptors
facilitated increased species-richness in autochthonous
microbial communities, for example, in the intestine? It is
important to note, however, that the elaboration of structur-
ally diverse antigen receptor repertoires by consecutive
rounds of gene duplication and diversification would have
been severely constrained by the resulting rapid increase
in genome complexity, with its attendant cost. By contrast,
somatic diversification of antigen receptor genes would
have offered an efficient (and elegant) solution to achieve
vastly diverse repertoires while requiring only a minimally
increased coding capacity of the genome. Is there evidence
to support this idea? Indeed, microbiomes of invertebrate
‘super-organisms’ are much more arid in terms of species
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Figure 3. Schematic illustrating the role of
a diversified antigen receptor repertoire in
mediating the elaboration of a species-rich
microbiome living on and in vertebrates.
It is proposed that the structural diversity of
antigen receptors generated by intra-epithe-
lial immune effector cells scales with the
species diversity of the autochthonous (resi-
dent) microbiome; this in turn establishes
stable metabolic interactions with the host
organism. At the same time, antigen receptors
additionally interact with transient (allotho-
nous) components of the microbiome; these
immune responses eventually regulate its
composition.
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R726diversity andmetabolic capacity [59] than those living on and
in vertebrates [60]. To examine how general these findings
are, it will be particularly important to examine the diversity
of autochthonous intestinal taxa in many different animal
species living in aquatic environments, for example, evolu-
tionarily ancient deuterostome species, such as acorn
worms and sea urchin, in addition to evolutionarily younger
chordates, such as cephalochordates and tunicates, and to
compare them with those in lower vertebrates such as
lamprey, hagfish and cartilaginous fish.
Sustaining a Species-Diverse Microbiome
The selective advantage of increasing antigen receptor
diversity with respect to the species-richness of micro-
biomes (Figure 3) is illustrated by the apparent role of
secreted antibodies, such as IgA in mammals, in the main-
tenance of microbial homeostasis on mucosal surfaces;
defective structural diversification of secreted antibodies is
associated with dysbiosis, which is characterized by gener-
ally lower species diversity and an ‘unhealthy’ composition
of the microbiome [61–70]. If the hypothesis that an immune
system employing somatically diversified antigen receptors
was required for the establishment of diverse microbiomes
is indeed true, then several predictions can be made. For
instance, it would be expected that evolutionarily older
vertebrates, such as fish, amphibians and reptiles, also
employ secretory immunoglobulins [71,72] for this purpose:
indeed, in teleosts, the IgT (also known as IgZ) isotype is
secreted into the intestinal lumen, where it coats the resident
microbes [71]. This functional flexibility is mirrored in the IgA-
deficient state of mammals, in which IgM can functionally
replace secreted IgA [73]. Remarkably, a pentameric form
of VLRB antibodies has been detected in lamprey [37];
however, it is unknown whether the structural analogies to
the secreted pentameric form of IgM also extend to func-
tional aspects, that is, the secretion into the intestinal lumen.
Another expectation is that the correlation between the
adaptive facilities of the immune system and the diversity
of associated microbiomes also holds for lower vertebrates.
This prediction can be tested using a series of recentlydescribed immunodeficient teleost
fish [74]; of particular interest are fish
that lack either all lymphocytes [75] or
only the B-lymphocyte lineage associ-
ated with expression of IgT/Z [76]. It
is also possible that chordates already
invented the principle of immune-mediated microbial management by secreting structurally
diverse immune-related molecules.
It has been suggested that variable-region-containing
chitin-binding proteins (VCBPs) expressed in the intestinal
tract of living chordates, such as amphioxus and tunicates,
are involved in shaping resident microbial communities
[77,78]. In amphioxus, several VCBPs are encoded by di-
verse, non-recombining and haplotypically variable alleles
[77], whereas the degree of polymorphism in other VCBPs
of amphioxus and in those of the ascidian Ciona intestinalis
is much less pronounced [78]. If no other polymorphic
immune-related receptors were secreted into the gut
lumen in these species, the prediction would be that the
autochthonous commensal communities in amphioxus are
more diverse than in C. intestinalis and that the higher
degree of diversity in some VCBPs of amphioxus reflects
adaptive changes to specific (presumably amphioxus-
specific) antigenic challenges from the allothonous flora.
In addition, the diversity of intestinal microbiomes in
different tunicate species (known to be quite variable with
respect to their super-organismic metabolic capacities
[79]) should scale with a species-specific degree of VCBP
polymorphism.
Hence, in addition to immune defense in the classical
sense, the elaboration and maintenance of a species-rich
community of commensalmicrobes through diverse immune
effectormoleculeswould have other benefits: it would estab-
lish unfavorable conditions for invading micro-organisms,
and in this way a form of non-specific protection against
infection, and, as a result of the ‘buffering’ effect with respect
to quantitative and qualitative perturbations of the com-
mensal flora, it would at the same time ensure stability of
metabolic capacities.
A Potential Drawback of the Super-Organismic Lifestyle
If the requirement for sophisticated host–microbemutualism
associated with vertebrate evolution was indeed the main
force underlying the emergence of somatic diversification
of antigen receptors, then there was a price to pay for
advanced metabolic functionalities and the other benefits
Special Issue
R727of the super-organismic life-style. As a result of the vast
diversity of antigen receptors generated by somatic diversifi-
cation, their inadvertent reactivity towards self-structures
potentially initiates self-destructive immune responses [80].
While Darwinian selectionweeds out potentially self-reactive
formsofgermline-encodedantigen receptors (suchasTLRs),
somatic diversification necessitates innovative solutions [5].
These are provided in the form of somatic quality control
that is orchestrated by the microenvironment of the emerg-
ing primary lymphoid organs within which lymphocytes
develop [81]. For instance, in the thymus, the site of T-cell
development [6], complex cellular and molecular mecha-
nisms underlying presentation of self-antigens [82] serve
the purpose of dealing with overly self-reactive lymphocytes
[83]. Hence, the emerging super-organisms traded invest-
ment into sophisticated mechanisms of somatic diversifica-
tion, quality control of antigen receptors and maintenance
of a functional immune system against the benefits of in-
creased metabolic capacity and non-specific pathogen pro-
tection. In this view, the residual level of autoimmunity
observed in vertebrates is perhaps not the result of faulty
design but rather the optimal solution to an essential aspect
of super-organismic lifestyle. If true, the mechanisms of
somatic quality control should have evolved (or been co-
opted from more ancient facilities) early in the evolution of
vertebrates [5,6,84].
Disorders of Host Defense
Infants with congenital neutropenia [85], X-linked agamma-
globulinemia [86], and severe combined immunodeficiency
(SCID) [87] exemplified the genetic basis of immunodefi-
ciency syndromes. Since then, the mutations underlying
many of these primary immunodeficiency disorders have
been identified and the Mendelian basis of clinically milder
forms of impaired immune functions uncovered [88,89].
Disorders of immune regulation manifest themselves as
autoimmunity, for example, following mutations in the auto-
immune regulator (AIRE) gene [90]; in other cases, excep-
tional susceptibility to specific infectious diseases results
in, for instance, chronic mucocutaneous candidiasis as a
result of mutations in genes encoding the cytokine IL-17F
and its receptor IL-17RA [91]. Indeed, in many cases, the
discoveries of disease-causing genetic aberrations in human
patients highlighted general phenomena, for instance, the
role of apoptosis [92,93] and regulatory cellular interactions
[94] in immune homeostasis. In humans, inborn errors of
immunity are probably best defined using clinical criteria,
laboratory parameters being, by necessity, in constant flux
as technology develops. Impaired immune functions can
lead to life-threatening infection and/or to autoimmunity;
in the pre-medical era, the former was almost certainly a
more significant problem than the latter.
Because of the enormous toll claimed by infections, it has
even been argued that most humans are inherently immu-
nodeficient [88], emphasizing the notion that, during the
evolutionary arms race between host and pathogens, the
latter constantly uncover new types of host susceptibility.
As a result, ongoing host–pathogen interactions manifest
themselves in signatures of Darwinian selection in immune-
related host genes. For instance, purifying selection is a
prominent feature of human type I interferons, indicating
their essential roles and hence their lack of functional
redundancy in the immune system [95]. Signs of adaptive
evolution, for instance, of genes encoding the patternrecognition machinery [96], indicate how environmental
factors, such as different pathogen spectra, are capable of
shaping immune functions in certain populations. Such
comparative studies shed light on the evolutionary conflict
between host and pathogens, for instance, the genetic
constraints on the compatibility of immune-related signaling
molecules and their receptors that are also used by viruses
to gain access to immune cells [97,98].
Animal Models Supporting Human Immunology
Research
The ‘experiments of nature’ manifesting themselves in
genetic disorders of immune system development and func-
tion have been replicated in forward genetic screens,
predominantly in mice [99,100], and also, albeit to a lesser
extent, in lower vertebrates, such as zebrafish [74,101] and
medaka [74]. These phenotype-driven screens, together
with comparative phylogenetic analyses, using the ever-
increasing number of complete vertebrate genomes, and
experimental perturbations in animals situated at various
points along the evolutionary trajectory, are beginning
to reveal the evolutionarily conserved core structures of
genetic networks regulating immune system development
and function [74]. To this end, the imminent elucidation of
the genome sequences of jawless and cartilaginous fishes
will provide critical additional information for the validation
of hypotheses concerning the structure of the immune
systems of lower vertebrates.
Comparative approaches have always been considered to
be important for immunological research. Pioneering work
on amphibians (for instance, [102]) and birds (for instance,
[103–106]) established key principles of lymphocyte and
lymphoid organ development and mechanisms of antigen
receptor diversification. Indeed, these animal models con-
tinue to prove their worth. For instance, versatile transgenic
procedures have been developed for the Xenopus model,
which, together with a well-developed armamentarium of
specific monoclonal antibody reagents and the powerful
procedures for tissue manipulation, reaffirm the importance
of amphibians for immunological research [107]. Likewise,
the unique facilities afforded by the DT40 chicken cell
line, which enables efficient gene inactivation owing to
a high rate of homologous recombination, have led to sig-
nificant insights into immune-related processes of DNA
modification [108].
Whereas the mouse model has risen to unchallenged
prominence, particularly due to the advantages of pre-deter-
mined geneticmodifications that are possible in this species,
additional animal models have slowly gained ground in
immunological research. In particular, the use of genetically
tractable fish species, such as the zebrafish, with unique
opportunities for time-lapse recording of hematopoietic
and immune cell development (for instance, [109]) and for
the monitoring of ongoing immune responses [110], has
led to major advances. Indeed, fish are a unique group of
vertebrates distinguished by their extraordinarily diverse
lifespans and ecology, thus promising to provide essential
information on immune function. For instance, the recent
discovery that a long-livedmarine fish, theAtlantic cod, lacks
the entire machinery of major histocompatibility complex
(MHC) class II-related antigen presentation has provided
insight into unprecedented alternatives of immune system
design distinguished by increased numbers of MHC class I
genes and genes encoding TLR-like pattern recognition
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Figure 4. Network-inspired therapy.
In the genetic network depicted on the left,
two positive effectors (arrows) and one inhib-
itory effector (T-shaped symbol) impact on the
activity of a downstream target that itself posi-
tively regulates the output function (bottom
circle). Following the inactivation of one posi-
tive upstream regulator by mutation, network
output diminishes. Output activity is restored
by correction of faulty gene function (top
right panel). A precise understanding of the
network structure suggests non-intuitive ther-
apeutic strategies, here exemplified by re-
moving the inhibitory function of an upstream
regulator (bottom right panel).
Current Biology Vol 22 No 17
R728receptors [111]. As another example, it was recently sug-
gested that IgD, an immunoglobulin found in mucosal
secretions as well as in the blood, plays an evolutionarily
conserved role in systemic immunity. IgD binding to cell-
surface receptors of basophils provides these innate cells
with information about the antigenic composition of, for
example, the respiratory tract and enables them to trigger
rapid innate responses [112]. Supporting the reawakening
of comparative vertebrate immunology is the growing im-
portance of genetically tractable invertebrate models, con-
tributing important information concerning evolutionarily
ancient components of hard-wired immune defenses; in-
structive examples are the discovery of pattern recognition
receptors in the fly [3] and histocompatibility systems in
ascidians [113].
If the biological diversity of vertebrates is to be harnessed
for the identification (and perhaps future therapeutic exploi-
tation) of core components of the immune system, surrogate
experimental systems to study particular features of geneti-
cally intractable species, particularly of fish, are urgently
needed. In some instances, the development of interspecific
transplantation models may offer an interesting path to
follow. For instance, zebrafish carrying a loss-of-function
mutation in the gene encoding the hematopoietic transcrip-
tion factor c-Myb were found to lack definitive hematopoi-
esis [75]. These fish are currently being tested for use
as universal recipients for cell and tissue transplants; this
is of considerable interest as the hosts do not require con-
ditioning prior to transplantation [74] and are themselves
amenable to genetic manipulation.
Treating Immune Dysfunction
The understanding of immune regulatory networks has
inspired numerous attempts to interfere with states of
dysregulation or malfunction and the lives of countlesspatients suffering from immunological
disorders have already been trans-
formed by the clinical application of
new strategies.
Clinical Application of
Immunological Insights
Amultitude of treatment strategies has
been developed to alleviate immune
dysfunction, some of which are illus-
trated below. Despite its conceptual
simplicity, the use of polyclonal IgGpreparations to treat patients with primary immunodefi-
ciencies has resulted in dramatic clinical improvements
[114], illustrating the contribution of a diverse immunoglob-
ulin repertoire for immune homeostasis. The development
and use of inhibitors of the potent pro-inflammatory cytokine
IL-1 to treat an etiologically heterogeneic group of autoin-
flammatory syndromes, characterized by episodes of fever
in the absence of activated T cells and autoantibodies and
presumably driven by abnormal responses of innate effector
cells [115], has met with extraordinary clinical success [116].
This treatment strategy is validated (and indeed mechanisti-
cally explained) by the fact that IL-1 and related cytokines are
the end-product of a stereotyped inflammatory response
mediated by the so-called inflammasome, a multiprotein
complex sensing the presence of a variety of microbial,
stress- and damage-related signals [117]. A similar clinical
success has been achieved with antibodies neutralizing the
activity of tumour necrosis factor (TNF), a cytokine that is ex-
pressed at very high levels in rheumatoid joint tissue [118].
While the above examples concern individual effector
molecules of the immune system, it has also been possible
to target its cellular components. For instance, the depletion
of B cells with antibodies against the B-cell lineage-specific
CD20 surface molecule benefits patients with autoimmune
disorders, such as multiple sclerosis [119], and those suf-
fering from certain B-cell malignancies [120]. As all immune
effector cells are descendants of the hematopoietic stem
cell, the clinical course of primary immunodeficiencies can
also be modulated by hematopoietic cell transplantation
[89], although allogeneic bone marrow transplantation is
associated with significant treatment-associated mortality.
Some disorders of immune regulation may also improve
upon adoptive cell transfer; an example for this strategy
is the use of ex vivo expanded antigen-specific T cells in
patients suffering from reactivated cytomegalovirus disease
Special Issue
R729[121]. In recent years, clinicians have begun to employ gene
therapy to treat monogenic immunological disorders, using
viral vector systems to transduce hematopoietic stem cells
to avoid problems with allogeneic transplantation proce-
dures; however, although a functional reconstitution of
genetic defects was achieved in the majority of patients,
severe side effects associated with vector-associated inser-
tional mutagenesis continue to limit the clinical usefulness of
this approach [122]. As a conceptual alternative, the use of
sequence-specific designer nucleases is advocated as
a novel means for the targeted correction of genetic lesions
[123,124] in the relevant tissue.
Future Strategies to Interfere with Failing Immunity
In addition to those strategies discussed above, recent
research hints at the possibility of developing alternative
strategies to alleviate failing immune functions. As the
genetic networks underlying the development of major cell
lineages and organs in the immune system are gradually
being revealed, comparative analyses using different verte-
brate species promise to help the delineation of core
elements of such networks. It may then be possible to at
least partially normalize the output of such networks,
not by restoring the function of faulty components but
rather by adjusting the resulting imbalance through interfer-
ence with other network components (Figure 4). For
instance, while Casp8-deficiency causes embryonic lethality
in mice, presumably owing to aberrations of intracellular
signaling pathways in immune cells, simultaneous disrup-
tion of Rip3, a gene functioning downstream of Casp8,
prevents lethality and restores initial immune competence
[125]. Thus, whereas the increasing information on genetic
interactions of immune-related genes [126–128] point to
the interdependence of gene functions, this information
might be exploited to develop non-intuitive treatment
strategies to alleviate the phenotype of certain genetic
defects. In addition, information on network structure could
be used, for instance, to manipulate lineage fate decisions
or to create artificial microenvironments for hematopoietic
cell differentiation. With regard to the latter and using
dysfunctional thymic epithelial cells as a starting point,
hematopoietic functions in mice have been engineered
in vivo by combinatorial expression of a limited number of
factors supporting attraction, proliferation and specification
of progenitor cells [129]; in this instance, the selection of
factors for the reconstitution was guided by information on
the physiology of single mutants in various species but
also by knowledge about their evolutionary trajectory.
Hence, phylogenetically informed and network-inspired
strategies hold great promise for the treatment of immune
system disorders.
In addition, unprecedented strategies for immune interfer-
ence could be developed by exploiting examples of evolu-
tionary remodeling of effector and signaling pathways,
such as those observed in the innate immune system of
the basal chordate amphioxus [130]. Furthermore, given
the intricate co-evolutionary relationship and functional
interdependence of host and microbiome, it might also be
possible to manipulate the microbiome in order to affect
the host immune system.While this appears to be an obvious
strategy to curb inflammatory bowel disease, it is also
possible that such interference would benefit patients
with systemic immune dysregulation, such as asthma and
allergies [58,131].Conclusions
The recent discoveries of alternative antigen receptor
systems in jawless vertebrates and of the unusual structure
of immune systems in certain fish species have led to a re-
newed interest in comparative immunology. Although most
immunological studies still focus on mammals (including
humans), it is anticipated that analyses of lower vertebrates
will provide additional unique insights into the core struc-
ture of adaptive immune systems, the modes of interaction
between their essential components, and the functional
and structural adaptations to different lifestyles and occu-
pancy of diverse ecological niches. This will lead to the iden-
tification of many more species-specific idiosyncrasies,
each of which will provide a potential blueprint for how failing
components might be compensated through augmentation
and/or rewiring of the genetic networks underlying immune
functions. In this way, comparative immunology may well
become a major driver for the development of non-intuitive
treatment strategies of human immunodeficiency and/or
immune deregulation.
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